Home1KJ • FRA
10X Genomics Inc
€13.82
Jan 29, 11:46:51 PM GMT+1 · EUR · FRA · Disclaimer
StockDE listed securityUS headquartered
Previous close
€13.68
Day range
€13.82 - €13.82
Year range
€12.16 - €46.29
Market cap
1.80B USD
Avg Volume
8.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
151.65M-1.30%
Operating expense
147.88M-0.70%
Net income
-35.75M61.55%
Net profit margin
-23.5861.04%
Earnings per share
-0.0284.16%
EBITDA
-32.52M26.12%
Effective tax rate
-3.82%—
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
398.16M11.56%
Total assets
937.79M-1.13%
Total liabilities
214.99M5.74%
Total equity
722.80M—
Shares outstanding
121.05M—
Price to book
2.29—
Return on assets
-11.11%—
Return on capital
-12.79%—
Net change in cash
(USD)Sep 2024Y/Y change
Net income
-35.75M61.55%
Cash from operations
21.64M185.52%
Cash from investing
-3.62M-173.84%
Cash from financing
156.00K-96.43%
Net change in cash
18.34M213.78%
Free cash flow
29.79M681.03%
About
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. Wikipedia
Founded
2012
Employees
1,259
Search
Clear search
Close search
Google apps
Main menu